Chesnara Plc: Fourth acquisition in two years
12 November 2026
For investors with an eye on the healthcare sector, Avadel Pharmaceuticals plc (NASDAQ: AVDL) presents an intriguing opportunity worth examining. Based in Ireland, this biopharmaceutical company..
For investors looking into the dynamic intersection of healthcare and technology, Weave Communications, Inc. (NASDAQ: WEAV) presents an intriguing opportunity. As of the latest data, this..
Kura Oncology, Inc. (NASDAQ: KURA) is making waves in the biotechnology sector with its impressive focus on cancer treatment innovations. The San Diego-based clinical-stage biopharmaceutical company..
SI-BONE, Inc. (NASDAQ: SIBN), a key player in the medical devices sector, is making waves with its innovative solutions aimed at tackling musculoskeletal disorders of the..
uniQure N.V. (NASDAQ: QURE), a prominent player in the biotechnology sector, has caught the attention of investors with its significant potential upside of 123.60%, according to..
GH Research PLC (NASDAQ: GHRS) has captured the attention of investors with its promising potential upside of 152.67%. This Dublin-based biotechnology firm, specializing in innovative treatments..
Regulus Therapeutics Inc. (NASDAQ: RGLS) is a biotechnology firm focused on developing innovative therapies to combat genetically based orphan diseases. Headquartered in San Diego, California, the..
Talkspace, Inc. (NASDAQ: TALK), a prominent player in the digital mental health space, offers a compelling case for investors seeking exposure to the burgeoning healthcare technology..
AMN Healthcare Services Inc (NYSE: AMN), a prominent name in the healthcare sector, is catching the eye of investors with a potential upside of 3.24%. Despite..
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a healthcare company based in San Diego, California, specializing in biotechnology. With a market cap of $874.85 million, Maravai..
Delcath Systems, Inc. (NASDAQ: DCTH) is drawing significant attention in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $364.16 million,..
Nurix Therapeutics, Inc. (NRIX), a burgeoning player in the biotechnology industry, presents a compelling case for investors eyeing high-growth opportunities in the healthcare sector. Based in..
Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage biopharmaceutical company, has captured the attention of investors with an eye-popping potential upside of 302.40%. With a market capitalization..
Immunome, Inc. (NASDAQ: IMNM) is making waves in the biotechnology sector, offering exciting prospects for investors looking to capitalize on its burgeoning pipeline of cancer therapies...
InnovAge Holding Corp. (NASDAQ: INNV) stands out in the healthcare sector as a unique player focusing on the needs of seniors through its PACE (Program of..
Neuropace, Inc. (NASDAQ: NPCE) is capturing attention in the healthcare sector, particularly within the medical devices industry, as its innovative solutions target a critical unmet need..
Investors with an eye on the healthcare sector may find Niagen Bioscience, Inc. (NASDAQ: NAGE) a compelling opportunity. With a market capitalization of $779.19 million and..
For individual investors with an appetite for high-risk, high-reward stocks, Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) offers a tantalizing opportunity. With a potential upside of over 110%,..
Phibro Animal Health Corporation (NASDAQ: PAHC), a prominent player in the healthcare sector, primarily focuses on the production and distribution of animal health and mineral nutrition..
Spyre Therapeutics, Inc. (NASDAQ: SYRE) is capturing investor attention with a staggering potential upside of 221.22%, as analysts remain bullish on this clinical-stage biotechnology firm. Focused..
